As described in part one of this series, the chart below shows expected sales differences between 2024 and 2025 grouped by therapeutic category. The leading drivers of growth have been singled out – as have those areas that are expected to undergo the largest sales contraction. It should be noted that this analysis only includes forecasts where covering analysts have assigned specific indications for the sales.
Of the total estimated net growth of $72bn, the top 10 therapeutic areas are expected to contribute over 73% of...